Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 20 , ISSUE 10 ( 2016 ) > List of Articles

CASE REPORT

An encounter with enalapril-induced resistant, life-threatening angioedema at rural health center in Botswana

Nikhil Anish, Abiy Gabremedhin

Keywords : angiotensin-converting enzyme inhibitor, difficult airway, enalapril, fresh-frozen plasma,Angioedema

Citation Information : Anish N, Gabremedhin A. An encounter with enalapril-induced resistant, life-threatening angioedema at rural health center in Botswana. Indian J Crit Care Med 2016; 20 (10):613-616.

DOI: 10.4103/0972-5229.192060

License: CC BY-ND 3.0

Published Online: 00-10-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Angioedema, a rare, potentially fatal and usually self-limiting adverse effect of therapy with enalapril, is always a challenging encounter for an intensive care specialist in a rural setup. Here, we present a 74-year-old female, who presented to the Emergency Department of Sekgoma Memorial Hospital, Serowe village, Botswana, with progressive swelling of her face, tongue and breathing difficulty just 2 days after starting tablet enalapril. She failed to respond to usual treatment with adrenaline, steroids, and H1-antihistaminic agent, but she responded well with intravenous fresh-frozen plasma infusion. This helped us manage a difficult airway situation in a less equipped rural health center.


PDF Share
  1. Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: Increased risk in patients of African origin. Br J Clin Pharmacol 1999;48:861-5.
  2. Pylypchuk GB. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema. Ann Pharmacother 1998;32:1060-6.
  3. Mogensen CE. Renoprotective role of ACE inhibitors in diabetic nephropathy. Br Heart J 1994;72 3 Suppl:S38-45.
  4. Kostis JB. Angiotensin converting enzyme inhibitors. II. Clinical use. Am Heart J 1988;116(6 Pt 1):1591-605.
  5. Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: Cutaneous kinin potentiation. Arch Dermatol 1980;116:902-5.
  6. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998;18:171-88.
  7. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005;165:1637-42.
  8. Slater EE, Merrill DD, Guess HA, Roylance PJ, Cooper WD, Inman WH, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988;260:967-70.
  9. Hedner T, Samuelsson O, Lunde H, Lindholm L, Andrén L, Wiholm BE. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1992;304:941-6.
  10. Frank MM. Urticaria and angioedema. In: Goldman L, Bennett JC, editors. Cecil Textbook of Medicine. 21 st ed. Philadelphia, PA: WB Saunders Co.; 2000. p. 1440-5.
  11. Markovic SN, Inwards DJ, Frigas EA, Phyliky RP. Acquired C1 esterase inhibitor deficiency. Ann Intern Med 2000;132:144-50.
  12. Warrier MR, Copilevitz CA, Dykewicz MS, Slavin RG. Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema. Ann Allergy Asthma Immunol 2004;92:573-5.
  13. Karim MY, Masood A. Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema. J Allergy Clin Immunol 2002;109:370-1.
  14. Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003;3:311-7.
  15. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002;347:621-2.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.